We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+13.04%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$12.9B
AUM Growth
+$1.9B
Cap. Flow
+$442M
Cap. Flow %
3.42%
Top 10 Hldgs %
34.89%
Holding
1,323
New
145
Increased
499
Reduced
420
Closed
63

Top Sells

Rank Stock Value
1
EQIX icon
Equinix
EQIX
+$261M
2
PLD icon
Prologis
PLD
+$67.9M
3
KRC icon
Kilroy Realty
KRC
+$67.2M
4
WELL icon
Welltower
WELL
+$62.1M
5
STOR
STORE Capital Corporation
STOR
+$56.9M

Sector Composition

Rank Sector Weight
1 Real Estate 60.68%
2 Technology 7.51%
3 Communication Services 3.68%
4 Healthcare 3.56%
5 Consumer Discretionary 3.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RUBY
1226
DELISTED
Rubius Therapeutics, Inc
RUBY
$1K ﹤0.01%
178
-272
-60% -$1.62K
TCDA
1227
DELISTED
Tricida, Inc. Common Stock
TCDA
$1K ﹤0.01%
110
-170
-61% -$1.3K
CLVS
1228
DELISTED
Clovis Oncology, Inc.
CLVS
$1K ﹤0.01%
+166
New +$840
AKUS
1229
DELISTED
Akouos Inc
AKUS
$1K ﹤0.01%
+65
New +$1.27K
AERI
1230
DELISTED
Aerie Pharmaceuticals
AERI
$1K ﹤0.01%
102
-159
-61% -$1.92K
CALA
1231
DELISTED
Calithera Biosciences, Inc
CALA
$1K ﹤0.01%
+7
New +$614
KLDO
1232
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$1K ﹤0.01%
+68
New +$558
ODT
1233
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$1K ﹤0.01%
+72
New +$1.11K
FLXN
1234
DELISTED
Flexion Therapeutics, Inc.
FLXN
$1K ﹤0.01%
109
-163
-60% -$1.89K
KDMN
1235
DELISTED
Kadmon Holdings, Inc.
KDMN
$1K ﹤0.01%
+323
New +$1.27K
CHMA
1236
DELISTED
Chiasma, Inc. Common Stock
CHMA
$1K ﹤0.01%
127
-110
-46% -$458
FPRX
1237
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$1K ﹤0.01%
+87
New +$1.09K
PAND
1238
DELISTED
Pandion Therapeutics Inc. Common Stock
PAND
$1K ﹤0.01%
+56
New +$779
PRVL
1239
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
$1K ﹤0.01%
64
-128
-67% -$1.62K
BDSI
1240
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$1K ﹤0.01%
222
-285
-56% -$1.1K
ACET icon
1241
Adicet Bio
ACET
$77.6M
$0 ﹤0.01%
2
ADMA icon
1242
ADMA Biologics
ADMA
$2.02B
-335
Closed -$1K
AER icon
1243
AerCap
AER
$23.4B
-5,824
Closed -$147K
APRE icon
1244
Aprea Therapeutics
APRE
$7.69M
$0 ﹤0.01%
+2
New +$951
ASMB icon
1245
Assembly Biosciences
ASMB
$498M
$0 ﹤0.01%
6
-10
-63% -$1.17K
BURL icon
1246
PUT
Burlington
BURL
$23.4B
-200
Closed -$25K
BYND icon
1247
Beyond Meat
BYND
$274M
-332
Closed -$55K
CERS icon
1248
Cerus
CERS
$575M
-871
Closed -$5K
CRBP icon
1249
Corbus Pharmaceuticals
CRBP
$165M
-14
Closed -$1K
CUK
1250
PUT
DELISTED
Carnival PLC
CUK
-900
Closed -$339K

Similar funds

Daiwa Securities Group's Q4 2020 Portfolio in Review

As of Q4 2020, Daiwa Securities Group held 1,323 positions worth $12.9B, up 17% from $11B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Daiwa Securities Group deployed $442M of net new capital in Q4 2020, opening 145 new positions and adding to 499 existing holdings. Its largest new stake was Apartment Income REIT Corp.: 2,533,191 shares worth $97.3M.

By sector, the portfolio is most concentrated in Real Estate at 61% of assets, down from 62% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Equinix, an estimated $261M trimmed.

  • Daiwa Securities Group's largest Q4 2020 buy was Apartment Income REIT Corp.: 2,533,191 shares worth $97.3M.
  • Daiwa Securities Group added most to Americold in Q4 2020, an estimated $166M increase.
  • Daiwa Securities Group's biggest Q4 2020 reduction was Equinix, cutting an estimated $261M.
  • Daiwa Securities Group fully exited NextEra Energy, Inc. 6.219% Corporate Units in Q4 2020, selling an estimated $16.6M.
  • Daiwa Securities Group's ten largest holdings make up 35% of its $12.9B portfolio in Q4 2020.
  • Daiwa Securities Group opened 145 new positions and closed 63 in Q4 2020.
  • Daiwa Securities Group's portfolio value rose 17% quarter-over-quarter to $12.9B.

Based on Daiwa Securities Group's 13F filing for Q4 2020, filed 4 Feb 2021.